Single-cell Analysis Market — Global Forecast

By -

The Global Single-cell Analysis Market is expected to reach $3.59 billion, at a CAGR of 16.5%

(EMAILWIRE.COM, February 15, 2019 ) The growth in this Single-cell Analysis Market is mainly driven by the technological advancements in Single-cell Analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of Single-cell Analysis Market in cancer research, a growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases.

Download PDF (Single-cell Analysis Market):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171955254

Single-cell Analysis Market: The objectives for this study are as follows

- To define, describe, and forecast the market based on products, cell type, technique, application, end user, and region.
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

Single-cell Analysis Market segmentation:

· based on products.

· based on cell type.

· based on techniques.

· based on Application

· based on end users.

· based on regions.

The Major Players Operating in the Single-cell Analysis Market:

The Single-cell Analysis market is highly fragmented in nature with several big as well as emerging players. Prominent players in this market include Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), General Electric Company (U.K.), Thermo Fisher Scientific Inc. (U.S.), Miltenyi Biotec (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Fluidigm Corporation (U.S.), NanoString Technologies, Inc. (U.S.), and Agilent Technologies (U.S.).

Geographical Detailed Analysis for Single-cell Analysis Market:

North America to dominate the market followed by Europe

Based on the region, the Single-cell Analysis market is segmented into North America, Europe, Asia, and Row. North America accounted for the largest share of the market, followed by Europe.

The large share of the North American market is attributed to factors such as increasing collaborations among prominent players, technological advancements and expanding biotechnology and pharmaceutical industries.

Factors such as increased incidence of diseases, government support for various research activities, and growing focus on stem cell research and regenerative medicine are expected to fuel the market growth in the European region.

Read More in Detailed (Single-cell Analysis):

https://www.marketsandmarkets.com/Market-Reports/single-cell-analysis-market-171955254.html

Media Contact

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more